TI
RCKT icon

Trexquant Investment’s Rocket Pharmaceuticals RCKT Stock Holding History

Trexquant Investment’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-37,613
Closed -$251K – 1814
2025
Q1 		$251K Buy
+37,613
New +$372K ﹤0.01% 1427
2021
Q2 		– Sell
-5,681
Closed -$252K – 1432
2021
Q1 		$252K Sell
5,681
-12,642
-69% -$694K 0.02% 845
2020
Q4 		$1M Buy
+18,323
New +$668K 0.11% 257
2019
Q1 		– Sell
-14,602
Closed -$216K – 1255
2018
Q4 		$216K Buy
+14,602
New +$242K 0.01% 889
2017
Q1 		– Sell
-5,931
Closed -$145K – 1283
2016
Q4 		$145K Buy
+5,931
New +$169K 0.02% 875

Other funds holding RCKT

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.6B AUM 48.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.69B AUM 86.67% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return